ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Weill Cornell Medicine at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Weill Cornell Medicine takes part in 3 sessions at ESMO 2026 in Madrid. Its work spans digestive cancer treatment, artificial intelligence and melanoma, including pembrolizumab with chemoradiotherapy for esophageal cancer.

OrganizationESMO 2026 Attendance
University & institute
Medical school and biomedical research institution in New York, NY.
Abstract
Fri Oct 23
13:50–14:00
Talk
Fri Oct 23
16:15–16:30
AI in tumor-agnostic oncology: Hype or hope?
Raising the bar for tumor-agnostic studies
Biomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Weill Cornell Medicine

Tell us what you sell and we’ll find the people at Weill Cornell Medicine most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction